The emergency use of Pfizer’s coronavirus vaccine is to be administered by next week on children aged 12 and above by the U.S. Food and Drug Administration.
FDA Recommends Pfizer Vaccine For Children
The FDA began planning to add an amendment targeting the age range to the vaccine’s emergency use permit after Pfizer’s study in youth found that its vaccination performed as well in teenagers as it did in adults, according to The New York Times. According to the Times, federal officials familiar with the agency’s plans who were not allowed to talk publicly conveyed the details.
Medical analysts called it a significant move forward in the U.S. vaccine program and applauded this announcement.
Vaccinating infants is critical to the population’s immunity, according to researchers, and it could put school officials, teachers, and parents at ease if millions of students were available for vaccines before school starts in September.
Dr. Ashish Jha, who is a dean of Brown University’s School of Public Health, said that the approval would be a watershed moment for families like his.
He told the Times that it really puts an end to any questions about being able to have a very regular fall for high school students. It’s fantastic for them, fantastic for schools, fantastic for families of children in this age group.
Nonetheless, with adult vaccine demand declining and most of the world clamoring for the abundance of American-made vaccines, some analysts believe the US should donate excess shots to India and other countries suffering from major outbreaks.
Jha, on the other hand, claimed that the United States currently has ample vaccine supply to both provide vaccines to young Americans and benefit the rest of the planet. According to data compiled by the Centers for Disease Control and Prevention, the United States had about 65 million doses distributed but not administered as of Monday, including 31 million doses of the Pfizer vaccine.
While more than 105 million adults in the United States have been completely vaccinated, 44 percent of American adults have yet to obtain even one injection.
Although most teens seem to be immune to extreme COVID-19, Dr. Anthony Fauci, Biden’s administrative top COVID-19 adviser, has emphasized the importance of extending COVID-19 vaccine initiatives to cover them as well as younger children.
Even though more than half of American adults have received at least one injection of a coronavirus vaccine, many scientists and public health researchers agree that herd immunity will not be achieved in the near future.
Instead, the outbreak is expected to become a manageable threat that will spread in the United States for years to come, causing hospitalizations and deaths in much smaller numbers, according to the Times.
The push for herd immunity persuaded many Americans that vaccination was worthwhile. Still, vaccine skeptics could use the latest thinking from public health authorities to stop getting vaccinated. Vaccinations, however, remain the secret to transforming the virus into a manageable challenge, according to scientists.
Herd immunity was projected to be present in 60-70 percent of the population. Most researchers, including Fauci, believed that once vaccines were affordable, the United States could achieve that level.
However, as vaccine delivery ramped up this spring, the threshold target increased, owing primarily to the virus’s advent of more infectious strains. This currently circulating form of the virus in the United States, known as B.1.1.7, which was first identified in the United Kingdom, is approximately 60% more contagious.
Experts now predict that the herd immunity rate is at least 80%. According to the Times, if more viral strains emerge, or if scientists discover that immunized individuals can still spread the virus, the threshold estimate will be raised again.